{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:13:41Z","timestamp":1794438821017,"version":"4.9.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.numecd.2021.02.003","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T05:44:08Z","timestamp":1613367848000},"page":"1516-1520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Can the in-hospital mortality gap between STEMI patients with and without diabetes mellitus be reduced? The cardio-renal hypothesis"],"prefix":"10.1016","volume":"31","author":[{"given":"Nicola","family":"Cosentino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Bonomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeness","family":"Campodonico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Veglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano M.","family":"De Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Marenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2021.02.003_bib1","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1056\/NEJM200004063421408","article-title":"Coronary heart disease in patients with diabetes","volume":"342","author":"Haffner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2021.02.003_bib2","doi-asserted-by":"crossref","first-page":"145615","DOI":"10.4061\/2011\/145615","article-title":"Recent US patterns and predictors of prevalent diabetes among acute myocardial infarction patients","volume":"2011","author":"Ovbiagele","year":"2011","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.numecd.2021.02.003_bib3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2337\/dc17-1732","article-title":"Prognostic value of the acute-to-chronic glycemic ratio at admission in acute myocardial infarction: a prospective study","volume":"41","author":"Marenzi","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.02.003_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/CIRCOUTCOMES.115.002365","article-title":"Predicting adverse outcomes after myocardial infarction among patients with diabetes mellitus","volume":"9","author":"Arnold","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.numecd.2021.02.003_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001090","article-title":"In-hospital mortality among patients with type 2 diabetes mellitus and acute myocardial infarction: results from the national inpatient sample, 2000-2010","volume":"3","author":"Ahmed","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2021.02.003_bib6","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2337\/dc19-0047","article-title":"Reduced cardio-renal function accounts for most of the in-hospital morbidity and mortality risk among patients with type 2 diabetes undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction","volume":"42","author":"Marenzi","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.02.003_bib7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/978-1-4939-7274-6_28","article-title":"Structural equation modeling","volume":"1666","author":"Stein","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.numecd.2021.02.003_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00006199-200401000-00009","article-title":"SPSS and SAS programming for the testing of mediation models","volume":"53","author":"Dudley","year":"2004","journal-title":"Nurs Res"},{"key":"10.1016\/j.numecd.2021.02.003_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1037\/a0031034","article-title":"Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros","volume":"18","author":"Valeri","year":"2013","journal-title":"Psychol Methods"},{"issue":"Supplement B","key":"10.1016\/j.numecd.2021.02.003_bib10","doi-asserted-by":"crossref","first-page":"B4","DOI":"10.1093\/eurheartj\/sus002","article-title":"Cardiovascular disease and diabetes: the vulnerable patient","volume":"14","author":"Hess","year":"2012","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.numecd.2021.02.003_bib11","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.2337\/db14-0020","article-title":"Diabetes and cardiovascular disease in older adults: current status and future directions","volume":"63","author":"Halter","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2021.02.003_bib12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.numecd.2021.02.003_bib13","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2021.02.003_bib14","doi-asserted-by":"crossref","first-page":"108112","DOI":"10.1016\/j.diabres.2020.108112","article-title":"Implications of the recent CVOTs in type 2 diabetes: which patients for GLP-1RA or SGLT-2 inhibitor?","volume":"162","author":"Dardano","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.numecd.2021.02.003_bib15","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.CIR.0000120505.91348.58","article-title":"Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion","volume":"109","author":"Nikolaidis","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2021.02.003_bib16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/db08-1193","article-title":"GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice","volume":"58","author":"Noyan-Ashraf","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2021.02.003_bib17","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/eurheartj\/ehr309","article-title":"Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction","volume":"33","author":"L\u00f8nborg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2021.02.003_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00395-019-0733-2","article-title":"Inhibition of sodium-glucose cotransporter-2 preserves cardiac function during regional myocardial ischemia independent of alterations in myocardial substrate utilization","volume":"114","author":"Baker","year":"2019","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.numecd.2021.02.003_bib19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1124\/jpet.118.253666","article-title":"Empagliflozin, an SGLT2 inhibitor, reduced the mortality rate after acute myocardial infarction with modification of cardiac metabolomes and antioxidants in diabetic rats","volume":"368","author":"Oshima","year":"2019","journal-title":"J Pharmacol Exp Therapeut"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475321000521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475321000521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:18:21Z","timestamp":1760545101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475321000521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0939475321000521"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2021.02.003","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can the in-hospital mortality gap between STEMI patients with and without diabetes mellitus be reduced? The cardio-renal hypothesis","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2021.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}